Maze Therapeutics MAZE
NASDAQ MAZE
$26.21 +0.34 (+1.32%)
As of: Sep 4, 2026 · 3:59 PM EDT

Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026)

Maze Therapeutics (MAZE) posted Asset Utilization Ratio of 0.05 for Q1 2026, up 111.65% sequentially from 0.42 in Q3 2025, and up 110.4% YoY from 0.02 in Q1 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

Maze Therapeutics (MAZE) Asset Utilization Ratio (2025 - 2026) Analysis & Trends

Maze Therapeutics has reported Asset Utilization Ratio for 2 years, with the latest figure at 0.05 in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 0.47
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.38
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 0.20
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 0.69
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 0.90
8 Royalty Pharma 28.45 Bn 27.61 Bn - 0.13
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.54
10 Maze Therapeutics 1.55 Bn 1.55 Bn - 0.04
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.04
Mar 31, 2026 0.05
Jun 30, 2025 0.01
Mar 31, 2025 0.58